There are multiple mechanisms for CFT’s neuro-protective action of various neurodegenerative diseases and the common suggestions, including upregulation of Glutamate transporter 1 (GLT-1) expression, attenuation of oxidative stress or neuro-inflammatory process and others already elucidated. The gene discussed is SLC1A2; the disease is neurodegenerative disease.